Did you know colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths in men and women in the U.S.? Although the mortality rate has been declining for several decades, the American Cancer Society (ACS) estimates there will be more than 135,000 new cases and over 50,000 deaths from the disease in the United States this year. This type of cancer is often called a “silent killer” since it is often symptom-free and not diagnosed until late stages.
However, there is some positive news about colorectal cancer — it is largely curable if detected early. According to the Centers for Disease Control and Prevention (CDC), 60 percent of colorectal cancer-related deaths could be avoided with early, regular screenings.
Quest Diagnostics offers an effective screening test that is simple and easy. The InSure®FIT™ test uses a water-based collection method, and studies show it is better at detecting stages I-III compared to the traditional Hemocult stool test1.
Innovative companies, health plans and concerned individuals are taking action and participating in colorectal cancer screenings. If your company is interested in finding out how to help reduce healthcare costs and help save lives through early detection, visit QuestForHealth.com, or call 1.800.654.7824.
1CANCER 2006 107(9)2152-59)